CompletedEUCTR 2005-001855-39
Chronos: Can the antidepressive response induced by sleep deprivation (wake-therapy) be sustained through continuous stabilisation of the diurnal rhythm and long term light treatment in patients wi...
This historical record does not confirm current site availability.
Historical research recordDenmarkDepression
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Denmark
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- Psychiatric Research Unit, Frederiksborg General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Denmark
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2005-001855-39
- Official title
Show the full official title
Chronos: Can the antidepressive response induced by sleep deprivation (wake-therapy) be sustained through continuous stabilisation of the diurnal rhythm and long term light treatment in patients wi...
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Denmark
Registry details
Historical country statuses
- Denmark — Completed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Psychiatric Research Unit, Frederiksborg General Hospital, a hospital or academic medical center.
Want to explore more studies?
Explore studiesRelated studies
Esketamine Nasal Spray Versus Quetiapine for Hard to Treat Depression
A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)